0001415889-23-002167.txt : 20230208
0001415889-23-002167.hdr.sgml : 20230208
20230208175603
ACCESSION NUMBER: 0001415889-23-002167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230207
FILED AS OF DATE: 20230208
DATE AS OF CHANGE: 20230208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guerin Mark Patrick
CENTRAL INDEX KEY: 0001607714
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 23600306
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
4
1
form4-02082023_100254.xml
X0306
4
2023-02-07
0001130598
Onconova Therapeutics, Inc.
ONTX
0001607714
Guerin Mark Patrick
C/O ONCONOVA THERAPEUTICS, INC
12 PENNS TRAIL
NEWTOWN
PA
18940
false
true
false
false
CFO AND COO
Common Stock
2023-02-07
4
M
0
6900
A
19976
D
Common Stock
2023-02-07
4
F
0
1785
1.36
D
18191
D
Restricted Stock Units
2023-02-07
4
M
0
6900
0
D
Common Stock
6900
13800
D
Restricted stock units convert into common stock on a one-for-one basis.
On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
/s/ Mark Guerin
2023-02-08